Skip to main content
Grant Details

Grant Number: 5R01CA133009-03 Interpret this number
Primary Investigator: Isaacs, William
Organization: Johns Hopkins University
Project Title: Genetics Variants in the Genome Predisposing to Aggressive PCA
Fiscal Year: 2011
Back to top


Abstract

DESCRIPTION (provided by applicant): Fortunately, most men diagnosed with prostate cancer (PCa) will not die from their disease, and some men diagnosed may not even require treatment for their cancers. However, on the other end of the spectrum, ~30,000 men annually die from PCa in the US alone. For these latter men, the concept of PCa as an indolent disease obviously does not apply. Understanding the molecular basis of aggressive PCa (aPCa) vs. indolent PCa (non-aPCa) is perhaps the most important basic, yet translational question in PCa biology. We hypothesize that multiple sequence variants in the genome confer risk to aPCa but not to non-aPCa. Taking advantage of the publicly available CGEMS genome wide association data, as well as the large and unique PCa patient population at Johns Hopkins Hospital (JHH), we propose a systematic genetic association study to confirm, fine map, and better characterize genetic risk variants for aPCa. We propose three specific aims: 1)Test the genetic variants implicated in the CGEMS study that distinguish aPCa from non-aPCa among ~3,000 aPCa and ~5,000 non-aPCa patients of European ancestry from the JHH, 2) Fine map the genomic regions for the SNPs implicated in Aim 1 among 3,000 aPCa and 5,000 non-aPCa patients of European ancestry from the JHH, and 3) Assess the association of the most significant SNPs found in Aim 2 with disease characteristics in all 8,000 patients, and with disease progression in a subset of patients that have follow-up data at JHH. In addition, we have two exploratory aims: 1) fine mapping of regions containing SNPs significant in European Americans in aPCa and non-aPCa in African Americans, and 2) testing for gene-gene interaction. Besides the obvious clues that the proposed research may provide in terms of etiologic mechanisms, this study may also lead to identification of new target genes and proteins for therapy and possible preventive strategies. Furthermore, the identification of multiple variants can lead to the development of a test panel that may improve prediction of aPCa risk.

Back to top


Publications

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.
Authors: Liu W. , Lindberg J. , Sui G. , Luo J. , Egevad L. , Li T. , Xie C. , Wan M. , Kim S.T. , Wang Z. , et al. .
Source: Oncogene, 2012-08-30; 31(35), p. 3939-48.
EPub date: 2011-12-05.
PMID: 22139082
Related Citations

Inherited susceptibility for aggressive prostate cancer.
Authors: Isaacs W.B. .
Source: Asian journal of andrology, 2012 May; 14(3), p. 415-8.
EPub date: 2012-04-30.
PMID: 22543676
Related Citations

Genome-wide association study identifies new prostate cancer susceptibility loci.
Authors: Schumacher F.R. , Berndt S.I. , Siddiq A. , Jacobs K.B. , Wang Z. , Lindstrom S. , Stevens V.L. , Chen C. , Mondul A.M. , Travis R.C. , et al. .
Source: Human molecular genetics, 2011-10-01; 20(19), p. 3867-75.
EPub date: 2011-07-08.
PMID: 21743057
Related Citations

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.
Authors: Lin D.W. , FitzGerald L.M. , Fu R. , Kwon E.M. , Zheng S.L. , Kolb S. , Wiklund F. , Stattin P. , Isaacs W.B. , Xu J. , et al. .
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011 Sep; 20(9), p. 1928-36.
EPub date: 2011-08-16.
PMID: 21846818
Related Citations

Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.
Authors: Sun J. , Kader A.K. , Hsu F.C. , Kim S.T. , Zhu Y. , Turner A.R. , Jin T. , Zhang Z. , Adolfsson J. , Wiklund F. , et al. .
Source: The Prostate, 2011-03-01; 71(4), p. 421-30.
EPub date: 2010-09-28.
PMID: 20878950
Related Citations

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.
Authors: Xu J. , Zheng S.L. , Isaacs S.D. , Wiley K.E. , Wiklund F. , Sun J. , Kader A.K. , Li G. , Purcell L.D. , Kim S.T. , et al. .
Source: Proceedings of the National Academy of Sciences of the United States of America, 2010-02-02; 107(5), p. 2136-40.
EPub date: 2010-01-11.
PMID: 20080650
Related Citations




Back to Top